Abstract
Small cell lung cancer (SCLC) is a highly aggressive disease and miRNAs may play an important role in modulating SCLC progression. We have previously screened 924 miRNAs and found that miR-886-3P was negatively associated with SCLC survival. In the current study, we further investigated the role of miR-886-3P mimic in regulating SCLC cell phenotypic alteration in vitro and xenograft tumor formation in vivo. We found that transfection of miR-886-3P mimic significantly inhibited SCLC cell proliferation, migration, and colony formation, and induced mesenchymal-epithelial transition (MET) by suppressing TGF-ß1 synthesis in vitro. Furthermore, intra-tumor injection of miR-886-3P mimic lead to necrosis and suppression of tumor invasion to the surrounding tissue in the subcutaneous xenograft tumor, and intra-vein injection of miR-886-3P mimic suppressed xenograft lung cancer growth in vivo. These findings suggested that miR-886-3P functions as a tumor suppressor in SCLC and thus, it might be a potential therapeutic molecule in the treatment of lung cancer.
Author supplied keywords
Cite
CITATION STYLE
Shen, J., Zhou, W., Bi, N., Song, Y. M., Zhang, F. Q., Zhan, Q. M., & Wang, L. H. (2018). MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer. Cancer Biology and Therapy, 19(12), 1185–1192. https://doi.org/10.1080/15384047.2018.1491505
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.